Cigna Group (NYSE:CI) reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day.
President and CEO Brian Evanko said the company has reshaped its portfolio over the past deca
McDonald's stock is near four-year lows as the company unveils an AI-driven pricing and loyalty engine, raising investor concerns over a possible Wendy's-style consumer backlash ahead of earnings.
Panico's acquisition represents 31% of his prior equity stake, bringing his direct position to nearly 185,000 shares despite a significant gap between purchase and current market prices.
Anthropic's leaked IPO prospectus reveals $161.2 billion in Broadcom lease obligations and $518 billion in total infrastructure commitments, raising questions about its ability to pay as it becomes Broadcom's top XPU customer.
GE Aerospace trades at a steep valuation premium despite stronger margins, while Lockheed Martin's defense dominance comes with heavy government concentration risk.
Hormel Foods (NYSE:HRL) has agreed to acquire value-added chicken company Brakebush Brothers, LLC for approximately $1.055 billion in cash, a transaction the company said would expand its foodservice presence and increase its exposure to the chicken category.
The deal is structured on a cash-free,
A.G. BARR (LON:BAG) reported first-half revenue growth of 8.5% to £247.4 million for fiscal 2026/27, as contributions from acquisitions and continued demand for its core soft-drinks brands offset temporary supply-chain disruption during the summer trading period.
Profit before tax rose 2.6% to £36.
Patrick's purchase brings his total beneficial ownership to 6.2 million shares worth $54.41 million, signaling confidence despite the stock's 42% decline over the past year.
Delcath Systems, Viking Therapeutics and AxoGen show growth potential backed by analyst Moderate Buy ratings and strong institutional ownership, despite risks like dilution and patent cliffs.
